Haloderm, Inc.

Warning LetterOpen

United StatesIssued Oct 6, 2020

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Letter Details

Firm: Haloderm, Inc.
Location: United States
FEI Number: N/A
Country: United States
Issue Date: October 06, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata available, the FDA issued a Warning Letter to Haloderm, Inc., a drug manufacturer, on October 6, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the metadata provided. The warning falls under FDA's drug regulation authority, though the specific issuing office is not identified in the available information. Additional details about the company's manufacturing practices, product quality, or compliance issues would require review of the complete Warning Letter.